Lantheus Holdings, Inc. (CIK 1521036) reported 5 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-08). Recent activity: Sell CATX (80,783 shares), Sell CATX (167,149 shares), Sell CATX (42,129 shares), Sell CATX (35,769 shares), Sell CATX (78,145 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-08 | Perspective Therapeutics, Inc. (CATX) | 10% Owner | Sell | 80,783 | $250,896 |
| 2026-09-08 | Perspective Therapeutics, Inc. (CATX) | 10% Owner | Sell | 167,149 | $526,051 |
| 2026-09-04 | Perspective Therapeutics, Inc. (CATX) | 10% Owner | Sell | 42,129 | $131,219 |
| 2026-09-03 | Perspective Therapeutics, Inc. (CATX) | 10% Owner | Sell | 35,769 | $111,574 |
| 2026-09-02 | Perspective Therapeutics, Inc. (CATX) | 10% Owner | Sell | 78,145 | $245,610 |
Source: SEC Form 4 filings · as of 2026-09-08